BetterLife Pharma Inc. Liquidation Value Calculator
BetterLife Pharma Inc.
Current Price: N/A
Loading calculator data...
Advanced: All 64 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| cash | ||||
| Cash total | $8,180 | CAD | ||
| liabilities_total | ||||
| Liabilities total | $7.59M | CAD | ||
Unmapped Tags (62)
| Assets Assets | $224,963 | CAD | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $260,500 | CAD | ||
| Interest Expense InterestExpense | $165,087 | CAD | ||
| Research And Development Expense ResearchAndDevelopmentExpense | $424,337 | CAD | ||
| Profit Loss ProfitLoss | $-3.62M | CAD | ||
| AccumulatedOtherComprehensiveIncome AccumulatedOtherComprehensiveIncome | $195,825 | CAD | ||
| AdjustmentsForDecreaseIncreaseInOtherCurrentAssets AdjustmentsForDecreaseIncreaseInOtherCurrentAssets | $42,688 | CAD | ||
| AdjustmentsForDecreaseIncreaseInTradeAccountReceivable AdjustmentsForDecreaseIncreaseInTradeAccountReceivable | $27,911 | CAD | ||
| AdjustmentsForIncomeTaxExpense AdjustmentsForIncomeTaxExpense | $0 | CAD | ||
| AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables | $108,830 | CAD | ||
| AdjustmentsForSharebasedPayments AdjustmentsForSharebasedPayments | $2.05M | CAD | ||
| CapitalReserve CapitalReserve | $27.71M | CAD | ||
| CashFlowsFromUsedInFinancingActivities CashFlowsFromUsedInFinancingActivities | $1.99M | CAD | ||
| CashFlowsFromUsedInOperatingActivities CashFlowsFromUsedInOperatingActivities | $-2.02M | CAD | ||
| ComprehensiveIncome ComprehensiveIncome | $-3.65M | CAD | ||
| ComprehensiveIncomeAttributableToNoncontrollingInterests ComprehensiveIncomeAttributableToNoncontrollingInterests | $-101,612 | CAD | ||
| ComprehensiveIncomeAttributableToOwnersOfParent ComprehensiveIncomeAttributableToOwnersOfParent | $-3.55M | CAD | ||
| CurrentAccruedExpensesAndOtherCurrentLiabilities CurrentAccruedExpensesAndOtherCurrentLiabilities | $4.50M | CAD | ||
| CurrentFinancialLiabilities CurrentFinancialLiabilities | $382,428 | CAD | ||
| CurrentLiabilities CurrentLiabilities | $7.54M | CAD | ||
| DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised | $94.98M | CAD | ||
| DeferredTaxExpenseArisingFromWritedownOrReversalOfWritedownOfDeferredTaxAsset DeferredTaxExpenseArisingFromWritedownOrReversalOfWritedownOfDeferredTaxAsset | $601,363 | CAD | ||
| DepreciationAndAmortisationExpense DepreciationAndAmortisationExpense | $0 | CAD | ||
| DepreciationExpense DepreciationExpense | $18,435 | CAD | ||
| DescriptionOfExpectedVolatilityShareOptionsGranted DescriptionOfExpectedVolatilityShareOptionsGranted | $1 | pure | ||
| DescriptionOfRiskFreeInterestRateShareOptionsGranted DescriptionOfRiskFreeInterestRateShareOptionsGranted | $0 | pure | ||
| DilutedEarningsLossPerShare DilutedEarningsLossPerShare | $-0 | CAD/shares | ||
| EffectOfExchangeRateChangesOnCashAndCashEquivalents EffectOfExchangeRateChangesOnCashAndCashEquivalents | $8 | CAD | ||
| Equity Equity | $-7.36M | CAD | ||
| EquityAndLiabilities EquityAndLiabilities | $224,963 | CAD | ||
| ExpectedDividendAsPercentageShareOptionsGranted ExpectedDividendAsPercentageShareOptionsGranted | $0 | pure | ||
| FinancialLiabilities FinancialLiabilities | $382,428 | CAD | ||
| ForeignExchangeLoss ForeignExchangeLoss | $275,182 | CAD | ||
| GainsLossesOnExchangeDifferencesOnTranslationNetOfTax GainsLossesOnExchangeDifferencesOnTranslationNetOfTax | $-30,584 | CAD | ||
| GainsLossesOnLitigationSettlements GainsLossesOnLitigationSettlements | $556,640 | CAD | ||
| IncreaseDecreaseInCashAndCashEquivalents IncreaseDecreaseInCashAndCashEquivalents | $-29,204 | CAD | ||
| IssuedCapital IssuedCapital | $79.97M | CAD | ||
| IssueOfConvertibleInstruments IssueOfConvertibleInstruments | $14,606 | CAD | ||
| KeyManagementPersonnelCompensation KeyManagementPersonnelCompensation | $2.71M | CAD | ||
| LoansPayableInDefault LoansPayableInDefault | $50,052 | CAD | ||
| NetForeignExchangeLoss NetForeignExchangeLoss | $275,182 | CAD | ||
| NoncontrollingInterests NoncontrollingInterests | $3.32M | CAD | ||
| NoncurrentFinancialLiabilities NoncurrentFinancialLiabilities | $0 | CAD | ||
| NumberOfSharesOutstanding NumberOfSharesOutstanding | $43.49M | shares | ||
| OperatingExpense OperatingExpense | $5.00M | CAD | ||
| OtherCurrentFinancialLiabilities OtherCurrentFinancialLiabilities | $7.31M | CAD | ||
| OtherGainsLosses OtherGainsLosses | $9 | CAD | ||
| PaymentsForShareIssueCosts PaymentsForShareIssueCosts | $1.68M | CAD | ||
| ProceedsFromIssueOfBondsNotesAndDebentures ProceedsFromIssueOfBondsNotesAndDebentures | $1.22M | CAD | ||
| ProceedsFromIssuingShares ProceedsFromIssuingShares | $705,000 | CAD | ||
| ProfessionalFeesExpense ProfessionalFeesExpense | $499,307 | CAD | ||
| ProfitLossAttributableToNoncontrollingInterests ProfitLossAttributableToNoncontrollingInterests | $-101,596 | CAD | ||
| ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity | $-3.52M | CAD | ||
| ProfitLossFromOperatingActivities ProfitLossFromOperatingActivities | $-5.00M | CAD | ||
| RetainedEarnings RetainedEarnings | $-118.60M | CAD | ||
| SalesAndMarketingExpense SalesAndMarketingExpense | $0 | CAD | ||
| TaxEffectOfForeignTaxRates TaxEffectOfForeignTaxRates | $-51,614 | CAD | ||
| TradeAndOtherCurrentPayablesToRelatedParties TradeAndOtherCurrentPayablesToRelatedParties | $1.48M | CAD | ||
| TradeAndOtherCurrentReceivables TradeAndOtherCurrentReceivables | $11,644 | CAD | ||
| WagesAndSalaries WagesAndSalaries | $2.42M | CAD | ||
| WarrantLiability WarrantLiability | $312,936 | CAD | ||
| WeightedAverageShares WeightedAverageShares | $123.87M | shares |
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.